Evidence map›Paper›PMID 41426325›Full record

ArticleFrontiers in oncology2025

Case Report: Popliteal arterial tumor embolus as the initial presentation of EGFR-mutant lung adenocarcinoma with pulmonary-vein invasion.

Yongchun Hong, Xinjing Ding, Jianghua Ding

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yongchun Hong *Cardiology Department, Jiujiang University Affiliated Hospital, Jiujiang, China.
Xinjing Ding *Hematology & Oncology Department, Jiujiang University Affiliated Hospital, Jiujiang, China.
Jianghua DingHematology & Oncology Department, Jiujiang University Affiliated Hospital, Jiujiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombotic events represent a common complication and the second leading cause of mortality among patients with non-small cell lung cancer (NSCLC). Nonetheless, it is exceedingly rare for thrombosis to manifest initially in atypical locations, such as the popliteal artery, in individuals with NSCLC. In this report, we present a case involving an elderly patient with NSCLC who initially exhibited acute thrombosis of the popliteal artery in the left limb. The patient underwent a salvage arterial thrombectomy followed by a transfemoral amputation. Pathological examination revealed that the thrombus was a tumor embolus. A chest CT scan identified a mass in the right lower lung with a maximum diameter of 2.8 cm, along with multiple pulmonary nodules and a clot in the right inferior pulmonary vein. Pathological analysis of the lung mass confirmed the presence of lung adenocarcinoma, thereby verifying that the tumor embolus originated from NSCLC. The patient subsequently received treatment with osimertinib, resulting in partial remission. In instances of thrombosis occurring in uncommon sites, it is crucial to consider the potential for tumor thrombus.

Indexed as

EGFR-mutant lung adenocarcinomainitial presentationpopliteal arterypulmonary-vein invasiontumor embolus

Identifiers

PMID41426325
PMCPMC12714646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.